Some of the factors that have been previously identified as predictors of better response to type 1 diabetes treatment include younger age at onset, higher levels of C-peptide (a marker of insulin production), lower HbA1c levels (indicating better long-term glucose control), absence of autoantibodies (suggesting a milder form of the disease), and fewer symptoms at diagnosis (20–22). Here, INS is linked to type 1 diabetes mellitus.